*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>(S)-N-(((S)-1,2,3,4-Tetrahydronaphthalen-1-yl)methyl)quinuclidin-3-amine</strong> is a chiral pharmaceutical intermediate synthesized via asymmetric hydrogenation or resolution. Its molecular formula is C<sub>19</sub>H<sub>26</sub>N<sub>2</sub>. This enantiopure compound serves as a critical scaffold for developing central nervous system active agents.</p>
<h3>Application</h3>
<ul>
<li>Pharmaceutical synthesis: Precursor for novel antipsychotic and analgesic drug candidates.</li>
<li>Research & Development: Used in structure-activity relationship (SAR) studies for receptor binding.</li>
<li>Custom Manufacturing: Supplied as high-purity API intermediates for contract development organizations.</li>
</ul>
<h3>Precautions</h3>
<p>Requires storage under inert atmosphere at 2-8°C to prevent racemization. Handle with appropriate PPE due to potential irritancy. Strictly regulated for clinical trials only; not for direct human consumption without formulation.</p>